BOURLA ALBERT — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
BOURLA ALBERT has filed 7 SEC Form 4 filings across 1 company in the last 90 days.
Profile
Albert Bourla (born January 21, 1961 in Thessaloniki, Greece) is a Greek-American executive who serves as the chairman and chief executive officer of Pfizer, the multinational pharmaceutical company. Bourla earned a Doctor of Veterinary Medicine from Aristotle University of Thessaloniki and an MBA from the Wharton School of the University of Pennsylvania. He joined Pfizer in 1993 and has held a series of leadership roles in Pfizer's vaccines, pharmaceuticals, and commercial operations in Europe, the United States, and globally. He was named chairman of Pfizer’s board in 2018 and became chief executive officer in 2019. Under his leadership, Pfizer developed and distributed the Pfizer-BioNTech COVID-19 vaccine and has pursued broader expansion of Pfizer's portfolio through strategic collaborations and acquisitions.
Albert Bourla (born January 21, 1961 in Thessaloniki, Greece) is a Greek-American executive who serves as the chairman and chief executive officer of Pfizer, the multinational pharmaceutical company. Bourla earned a Doctor of Veterinary Medicine from Aristotle University of Thessaloniki and an MBA from the Wharton School of the University of Pennsylvania. He joined Pfizer in 19…
How many SEC Form 4 filings has BOURLA ALBERT submitted recently?
7 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of BOURLA ALBERT's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
